Stereochemical Assignment of Strigolactone Analogues Confirms Their Selective Biological Activity by Artuso, Emma et al.
 1 
Stereochemical Assignment of Strigolactone 1 
Analogues Confirms their Selective Biological 2 
Activity 3 
Emma Artuso,
†
 Elena Ghibaudi,
† 
Beatrice Lace,
†
 Domenica Marabello,
†
 Daniele Vinciguerra,
†
 4 
Chiara Lombardi,
†
  Hinanit Koltai,
┴
 Yoram Kapulnik,
┴
 Mara Novero,
‡
 Ernesto G. Occhiato,
§
 5 
Dina Scarpi,
§
 Stefano Parisotto,
†
 Annamaria Deagostino,
† 
Paolo Venturello,
† 
Einav Maylish-Gati,
 
6 
┴
 Ariel Bier,
┴ 
and Cristina Prandi
†,*
 7 
†
Department of Chemistry, University of Turin, via P. Giuria 7 10125 Turin, Italy 8 
‡
DBIOS, University of Turin, viale Mattioli 25, 10125 Turin, Italy. 9 
§Department of Chemistry “Ugo Schiff”, University of Florence, via della Lastruccia 13, 50019 10 
Sesto Fiorentino, Italy 11 
┴
ARO Volcani Center Bet Degan Israel. 12 
  13 
 2 
ABSTRACT: Strigolactones (SLs) are new plant hormones with various developmental 1 
functions. They are also soil signalling chemicals that are required for establishing beneficial 2 
mycorrhizal plant/fungus symbiosis. In addition, SLs play an essential role in inducing seed 3 
germination in root-parasitic weeds which are one of the seven most serious biological threats to 4 
food security. There are around 20 natural SLs that are produced by plants in very low quantities. 5 
Therefore, most of the knowledge of SLs signal transduction and associated molecular events is 6 
based on the application of synthetic analogues. Stereochemistry plays a crucial role in the 7 
structure-activity relationship od SLs as compounds with unnatural D-ring configuration may 8 
induce biological effects that are unrelated to SLs. We have synthesized a series of strigolactone 9 
analogues, whose absolute configuration has been elucidated and put in relation with their 10 
biological activity, thus confirming the high specificity of the response. Analogues bearing the 11 
R-configured butenolide moiety showed enhanced biological activity which highlights the 12 
importance of this stereochemical motif. 13 
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Strigolactones (SLs) are a new class of plant hormones whose potential in agricultural 1 
applications has been fuelling intense applied and pure research, both applied and pure.
1
 They 2 
have recently been assessed as a new class of plant hormones having effects on shoot branching
2
, 3 
root development,
3
 photomorphogenesis,
4
 besides acting as signalling molecules in the 4 
rhizosphere where they induce hyphal branching in arbuscular mycorrhizal fungi (AMF)
5
 and 5 
seed germination in parasitic plants.
6
 Natural SLs all share the same basic framework which 6 
consists of a tricyclic ABC nucleus connected with a butenolide moiety (D-ring) by means of an 7 
enol ether bridge (Figure 1).
1b
 They can therefore, be classified as Michael acceptors. More than 8 
20 natural SLs have been identified
1a,7
 while it is likely that others will be found in the near 9 
future.  This leads to questions as to why plants produce blends of SLs and whether quantitative 10 
and qualitative differences in SL production and/or exudation are important in host recognition.
8
 11 
More recently still, SLs and analogues have even been shown to act as promising anticancer 12 
agents.
9,10
 Strigolactones are very active molecules and indeed occur in very low abundances in 13 
root exudates, which is why assessments of their biological activity and unambiguous 14 
configurational assignments are often hampered.
1a
 The structural characterization of natural SLs 15 
and  extensive structure-activity studies (SAR) have revealed that the bioactiphore resides in the 16 
CD-ring (Figure 1) portion of the molecule. This has enabled the design and synthesis of SL 17 
analogues that show much simpler structures than natural SLs but still retain their bioactivity.
11
  18 
Most natural SLs show (2′R) absolute configuration while the correct configuration of (-)-19 
orobanchol (3) has recently been unequivocally confirmed.
12
 It is now generally accepted that 20 
SLs can be stereochemically grouped into two families (Chart 1), one in which the configuration 21 
of the BCD-ring  system is the same as (+)-strigol (1) and the other in which the configuration of 22 
the BCD-ring  system is the same as (-)-orobanchol (3).
13
  23 
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 1 
Figure 1. General structures and configurations of some natural SLs and of the synthetic 2 
analogue  (+)-GR24 3 
An analysis of mutants that are insensitive to pharmacological applications of SLs has led to the 4 
identification of DAD2 in petunia as the putative receptor that is able to hydrolyze SLs.
14
 DAD2, 5 
AtD14 (Arabidopsis thaliana),  and D14 (Oryza sativa) have been assessed by X-ray analysis 6 
and found to belong to the α,β-hydrolases family.15 In A. thaliana,  α,β-hydrolases KAI2 and 7 
AtD14 are responsible for responses to karrikins,
16
 chemical compounds found in plant-derived 8 
smoke,
17
 and SLs respectively. It was recently demonstrated that AtD14 and KAI2 exhibit 9 
selectivity to the 2′R or 2′S strigolactone D-ring configurations, respectively. However, AtD14 10 
mediates SLs response only while KAI2 mediates responses to KARs and to some SLs 11 
analogues.
18
 Structure Activity Relationship studies on shoot branching inhibition in rice and 12 
Arabidopsis have recently demonstrated that the (2′R) configuration has significant influence on 13 
hormonal activity.
19
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An assessment of the configurations of SLs and analogues is therefore mandatory to avoid the 1 
activation of responses that are not related to SLs and therefore the misinterpretation of our 2 
results. Furthermore, the use of pure stereoisomers can furnish valuable information as to the 3 
structural requirements for distinct perception systems in plants, parasitic weeds, and arbuscular 4 
mycorrhizal fungi. 5 
Difficulties in synthesizing natural SLs, caused by the long multistep syntheses, and their low 6 
availability from natural sources have prompted chemists to develop synthetic analogues that are 7 
readily accessible in sizeable quantities, stable, and whose activity may be related to that of 8 
natural SLs. One added advantage of this approach is the ability to obtain more information 9 
about the structural requirements for the activation of specific perception systems and the 10 
specificity of the target functions. Our contribution to the field has been the development of a 11 
family of indolyl derived analogues named EGOs.
20
 12 
The synthetic procedure is feasible as it starts from inexpensive reagents and multigram 13 
preparations are readily accomplished. The analogues were designed with the specific  aim of 14 
reducing  stereochemical complexity, and the only stereocenter retained is the C-2′ position. 15 
Compounds that are obtained as racemic mixtures are readily separated by chiral semipreparative 16 
HPLC (Figure 1S, Supporting Information). Several biological assays have been carried out on 17 
various target systems using EGO analogues
21
 in the past and some new ones are herein 18 
presented. However, the elucidation of the absolute configuration of pure enantiomers, is 19 
described here for the first time.  20 
In this paper we report the assignment of the absolute stereochemistry of parent EGO10 21 
compounds (5, 6 Figure 2) by X-ray analysis and electronic circular dichroism (ECD), and  the 22 
 6 
configurations of the other members of the family, by comparing ECD data is described. Once 1 
the absolute configurations of the pure enantiomers are established, we then correlate some past, 2 
and other unpublished results with the biological effects induced by the EGO analogues, thus 3 
shedding light on the importance of configuration in SLs response. An EGO10 derivative 4 
(MEB55), which is active as an anticancer agent, and some fluorescent tagged analogues 5 
(EGOBP and BPGR24), which are used for bio-imaging applications, are included among the 6 
analogues taken into consideration.. 7 
RESULTS AND DISCUSSION 8 
Chemistry. Our interest in developing new synthetic SL analogues has manifested in two 9 
principle aims: a) to extend the structure-activity relationship in varying systems for each of the 10 
different roles ascribed to SLs, and b) to develop active fluorescent SL analogues that are 11 
suitable for bioimaging studies and in vivo detection to map strigolactones distribution in plants 12 
and fungi. We have recently reported the synthesis of a new class of Strigolactone analogues that 13 
show interesting luminescent properties.
22
 We have also developed a new class of indolyl 14 
derived compounds named EGO which can be functionalized with different substituents on the A 15 
ring.
21b,23
 Furthermore in view of the use of SL analogues as fluorescent probes in the in vivo 16 
mapping of the dynamic processes in which SLs are involved, we have designed a new 17 
generation of fluorescent analogues whose properties are suitable for confocal microscopy 18 
investigations using the well-known fluorescent BODIPY based probes.
24
  19 
 7 
 1 
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Figure 2. Series of SL analogues as pure enantiomers 3 
EGO10 (5, 6) and MEB55 (7, 8) were synthesized as previously described.
21b,23
EGOBP A (9) 4 
and EGOBP B (10) were synthesized and used for in vivo visualization.
22
 In addition, SL 5 
analogue GR24 (4) was used as the core structure due to its widespread use as a standard for 6 
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 8 
biological assays. The fluorophore BODIPY can be linked to GR24. To this purpose amino-1 
GR24 (19, Scheme 1) was synthesized from nitro- derivative 15, but with a slight modification to 2 
the reported procedure.
25
 Compound 18 was obtained as a mixture of stereoisomers, more 3 
specifically as two racemic diastereomers which were separated by column chromatography. 4 
From this point onwards, the reactions were carried out on the separate diastereomers. 5 
Scheme 1. Synthetic procedure to BPGR24 as a mixture of stereoisomers
a
 6 
 7 
 8 
a
Reagents and conditions: (i) Zn/CaCl2, EtOH-H2O, reflux, 2 hs (80%);  (ii) t-Boc2O, DMAP, THF, 9 
reflux, 18 h (80%);  (iii) HCOOEt, t-Boc2O, DME, rt, 2 h then 5-bromo-3-methylfuran-2(5H)-one, rt,.18 10 
hs (62%); (iv) TFA, DCM, rt, 2h (93%); (v), CDMT, NMM, DCM, rt, 18 h (78%). 11 
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 9 
After the introduction of the D-ring, compound 18 was deprotected and coupled with the 1 
corresponding BODIPY fragment 20 according to the Kaminski procedure and obtained with a 2 
78% yield.
26
 The racemic mixtures were then separated via chiral HPLC (Figures 4 and 5, 3 
Supporting Information) and the four stereoisomers (+) BPGR24 (11), (-) ent BPGR24 (12), (+) 4 
2′-epi BP GR24 (14) and (-) ent 2′-epi BP GR24 (13) were fully characterized. The absolute 5 
configurations were determined on the base of ECD data as described in the next section, and via 6 
a comparison of chromatographic behavior with parent GR24 standards. 7 
X-ray Analysis. Crystals of EGO10A (5) that were suitable for X-ray diffraction analysis were 8 
obtained via the slow evaporation of a methanol solution. Since the molecule is only composed 9 
of light atoms, X-ray data were collected using Cu-K radiation (=1.5418 Å), which furnishes a 10 
more accurate determination of absolute configuration even when heavy atoms are not present  in 11 
the molecule. The ORTEP plot of the molecule is shown in Figure 3. 12 
 13 
Figure 3. ORTEP plot of compound EGO10A (5) with atom labelling. Thermal ellipsoids of 14 
non-hydrogen atoms are represented at 50% probability. 15 
Although the diffraction capability of the crystal was low, the data collected were sufficient to 16 
unequivocally determine the absolute configuration, via the Parsons method.
27
 As shown in 17 
 10 
Figure 3 the resulting absolute configuration of compound EGO10A is R at the C-1 (C-2′) 1 
stereocenter.
28
 2 
ECD Measurements. The ECD spectra of submillimolar solutions of each of the EGO10 (5, 6) 3 
and EGOBP (9, 10) stereoisomer were recorded in MeCN, in order to collect evidence for the 4 
absolute configuration of the C2′ stereocenter. 5 
   6 
Figure 4 -  Panel A: ECD spectra of EGO10 A (5, a) and B (a′), EGOBP A (9, b) and B (10, b′), 7 
MEB 55 A (7, c) and B (8, c′); Panel B: ECD spectra of BPGR24 (11, d) ent-BPGR24 8 
(12, d′), ent-2′-epi-BPGR24 (13, e) and 2′-epi-BPGR24 (14, e′). R stereoisomers at C-2′ 9 
are outlined in black; S stereoisomers at C-2′ are outlined in dark grey. All stereoisomers 10 
were dissolved in MeCN at submillimolar concentration. 11 
 12 
Figure 4 (panel A) shows the ECD spectra of enantiomers A and B of EGO10, EGOBP and 13 
MEB55 in the 200-300 nm region. All these compounds contain a single C-2′ stereocenter. 14 
 11 
Labels A and B were initially assigned according to enantiomer  HPLC behaviour: the A species 1 
eluted before the B species in our experimental conditions (see HPLC chromatograms in Figures 2 
1S-5S in Supporting Information).  The spectroscopic patterns associated with the three 3 
‘stereoisomers A’ share similar features, and the same is true for the ‘stereoisomers B’ set. The 4 
full ECD spectra of these compounds in the 200-450 nm range are reported in the Supporting 5 
Information (Figures 6S and 7S). The stereochemical assignments of SLs stereocenters by ECD 6 
spectroscopy generally relies on the empirical rule proposed by Frischmuth et al.
29
 According to 7 
this rule, compounds that exhibit a negative Cotton effect around 270 nm have a 2′R 8 
configuration, whereas a positive Cotton effect band is typical of 2′S configuration. The rule is 9 
grounded on two basic assumptions: i) an absence of electronic interactions between 10 
chromophoric systems C and D; ii) the conformational identity of C-2′ epimers. According to 11 
these assumptions, rings C and D provide independent contributions to the ECD spectrum and 12 
the region around 270 nm is mainly related to electronic transitions that involve the ring D 13 
chromophore. Despite the clearly approximate character of such assumptions, the rule has proven 14 
to be effective for a number of strigolactone stereoisomers.
30
 As far as EGO10, EGOBP and 15 
MEB55 compounds are concerned, stereoisomers A exhibit a negative Cotton effect  band 16 
around 270 nm; hence, according to Frischmuth’s rule, the absolute configuration of the C-2′ 17 
center is R in all three compounds, whereas stereoisomers B possess a C-2′S absolute 18 
configuration.  This assignment is supported and confirmed by a number of consistent pieces of 19 
evidence. In fact, the X-ray structure of EGO10 A (5)  unambiguously shows a C-2′R 20 
configuration. In addition, the three stereoisomers that belong to set A are chemically correlated, 21 
in that they are obtained via a synthetic procedure that cannot perturb stereocenter C-2′. The 22 
same is true for set B. Hence each set must share the same absolute configuration at C-2′’. 23 
 12 
Further supporting evidence is the fact that the chromatographic behavior of stereoisomers A 1 
stereoisomers A vs. B towards chiral phases is homogeneous within sets. This argues in favour 2 
of the same C-2′ absolute configuration in each set of molecules. All the evidence collected for 3 
EGO10, EGOBP and MEB55 is consistent with the assignment of the C-2′R configuration to set 4 
A and the C-2′S to set B. Figure 4 (panel B) shows the ECD spectra of the four diastereoisomers 5 
BPGR24 (11), ent-BPGR24 (12), 2′-epi-BPGR24 (14) and ent-2′-epi-GR24 (13, Figure 2). These 6 
compounds exhibit peculiar ECD spectral patterns, unlike the previous sets of molecules as do 7 
other known strigolactones. In particular, no sign inversion is observed for the Cotton effect in 8 
the 200-350 nm range and the Frischmuth’s rule is no longer applicable. This is probably related 9 
to the disappearance of the premises upon which the rule was grounded: either conformational 10 
issues influence the spectral pattern or the claimed electronic independence of ring C and D can 11 
no longer be assumed. A completely unambiguous assignment of the absolute configuration in 12 
the presence of conformational or electronic factors mayt require a complex approach, based on 13 
the combination of ECD, VCD and theoretical calculation.
31
 Nevertheless, the combination of 14 
several distinct experimental findings (X-ray structure, ECD data, chemical correlation, and 15 
chromatographic behaviour) provides sufficient evidence for configurational assignment by 16 
analogy. In fact, as these compounds are GR24 derivatives, ECD spectra may be analyzed by 17 
comparison with the well-known CD patterns of GR24 and its diastereoisomers 
32
(see Figure 7S, 18 
Supporting Information) which do not follow Frischmuth’s rule either. (+) GR24 (4)  has been 19 
definitely shown by Scaffidi and coworkers  to display a C-2′R configuration and its ECD 20 
spectrum exhibits a positive Cotton effect in the 210-260 nm range. Both BPGR24 (11) and ent-21 
2′-epi-BPGR24 (12) show positive Cotton effect in the very same spectral region, which would 22 
suggest an analogous C-2′R configuration for both of them. The distinct features of the ECD 23 
 13 
patterns of diastereoisomers BPGR24 (11) and ent-2′-epi-BPGR24 (12) are certainly related to 1 
differences in the electronic energy levels: ent-2′-epi-BPGR24 (13) exhibits three resolved 2 
Cotton effect  while BPGR24 (11) shows only two. However, the Cotton effect at ~230 nm is 3 
clearly not a pure Gaussian curve, which means that it is the convolution of more than one 4 
contribution. Hence, the ECD spectra of BPGR24 and ent-2′-epi-BPGR24 are consistent overall. 5 
Further arguments in support of the C-2′R assignment for BPGR24 and ent-2′-epi-BPGR24 are 6 
the chemical correlation between these two stereoisomers and (+)-GR24 as well as analogies in 7 
the chromatographic behaviour of the species. In conclusion, ECD data collected on the EGO 8 
and BPGR24 series of strigolactones clearly show that EGO derivatives fulfil Frischmuth’s rule, 9 
whereas BPGR24 derivatives do not. Experimental evidence converges towards the assignment 10 
of R configurations for the C-2′ stereocenter of EGO10 A (5), EGO-BP A (9), MEB55 A (7), 11 
BPGR24 (11) and ent-2′-epi-BPGR24 (13). 12 
Biological activity. The simplest molecules that were separated as pure enantiomers were 13 
EGO10 A (5) and EGO10 B (6) whose absolute configuration corresponds to R for EGO10 A 14 
and S for EGO10 B, as demonstrated by X-ray analysis and ECD data. 15 
 14 
 1 
Figure 5. Bar graph representation of germinated seed percentages (Y axis) of Phelipanche 2 
aegyptiaca after exposure to pure enantiomers of EGO10 A and B.  3 
 4 
Figure 6. Bar graph representation of hyphal branching number per hyphal apex of Gigaspora 5 
margarita after exposure to the two pure enantiomers of EGO10 A (R) and EGO10 B (S). 6 
Figures 5 and 6 clearly show that enantiomers EGO10 A and EGO10 B exhibit significantly 7 
different activity in the hyphal branching test, EGO10 A (R) is the most active, while conversely, 8 
0,00%
10,00%
20,00%
30,00%
40,00%
50,00%
60,00%
70,00%
80,00%
90,00%
100,00%
water GR24 EGO 10 A 10-6M EGO 10 B 10-6M
EGO 10 A and B 
germination activity on Peliphanche eagyptiaca 
0
2
4
6
8
10
12
14
16
18
20
Water GR24 EGO 10 A 10-6 M EGO 10 B 10-6 M
EGO 10 A and B 
hyphal branching on Gigaspora margarita 
a 
b 
b 
b 
b b 
a 
a 
 15 
the activity of these enantiomers on Peliphanche aegyptiaca seeds does not show any statistical 1 
difference. 2 
This result is consistent with the recently reported data, according to which the non-natural 3 
enantiomer of SLs can activate biological responses through perception systems unrelated to 4 
SLs.
32
  5 
Root Hair Elongation. The hormonal activity of the enantiomers of EGO10 on root hair 6 
elongation has also been evaluated on Arabidopsis thaliana, using a well-established protocol.
33
 7 
Racemic EGO10’ s strong positive effect on RH elongation has already been demonstrated.34 8 
 9 
Figure 7. Root hair length (µm) in root segments of Arabidopsis thaliana after exposure to 10 
EGO10 A (R) and EGO10 B (S), EGO10-mD at 0.1 µM concentration. 11 
As shown in the bar graph in Figure 7, the effect of EGO10A (R) is statistically larger than that 12 
of its enantiomer EGO10B (S). In addition the effect of EGO10 without the D-ring (EGO10-mD) 13 
was considered in order to demonstrate the role of the enol ether bridge and the D-ring in 14 
inducing biological effects. In fact, EGO10-mD was as ineffective as EGO10 B.  15 
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 16 
MEB55. Thiophene derivatives were synthesized according to known procedure and separated 1 
into pure enantiomers (see Figure 2S, Suppporting Information). The activity of racemic 2 
mixtures of MEB55 had already been tested on Peliphanche aegyptiaca seeds and good activity 3 
was reported.
23
  4 
We next measured the activity of enantiomers at the same concentration at which the racemic 5 
mixture proved to be most active. As shown in Figure 8 the two enantiomers behave differently, 6 
MEB55 A (7, 2′R) is much more active than both MEB55 B (8, 2′S) and racemic GR24 which 7 
was used as a standard.  8 
 9 
Figure 8. Bar graph representation of percentages of germinated (Y axis) of Peliphanche 10 
aegyptiaca seeds after exposure to pure enantiomers of MEB55 A (7, R) and B (8, S) at 0.1 µM 11 
concentration. 12 
 13 
We recently reported the antiproliferative activity of some SL analogues.
9
 After an initial 14 
screening of EGO10 derivatives with various substitutions on the A ring, those with a thienyl 15 
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 17 
(MEB55) and dioxathienyl substituent at C-7 were found to be the most potent and promising 1 
candidates for anticancer therapy due to their ability to specifically induce cell cycle arrest, 2 
cellular stress, and apoptosis in cancer line cell with minimal effects on normal cells growth and 3 
survival. Two different cell lines have been tested for their response to enantiopure SL 4 
analogues. The first line BJ is a normal cell line established from human neonate fibroblasts 5 
(skin, foreskin), while the second MDA-MB-231 is from human breast cancer cells (epithelial, 6 
adenocharcinoma disease).
9
 Enantiomer activity on cell lines was quantified as the effect on cell 7 
viability, using XTT (see Experimental Section). As shown in Figure 9, the normal cell line BJ is 8 
insensitive to the application of SL analogue application while the viability of the tumour cell 9 
line MDA-MB-231 is affected by SLs. In particular, one of the two enantiomers MEB55 A (7), 10 
which corresponds to the 2′R configuration (red bar, Figure 7) was found to be much more active 11 
than the S stereoisomer. The racemic mixture  (purple bar, Figure 9) and the equimolar mixture 12 
of R and S enantiomers, created in order to have an additional control (light blue), show activity 13 
which is similar to the most active R enantiomer indicating that the S enantiomer does not 14 
possess antagonist activity.  15 
 16 
 18 
  1 
Figure 9. Bar graph representation of cell viability test on cell lines BJ and MDA-MB-231 in the 2 
presence of MEB55 (2500 were seeded per line). These were treated with a 7.5 M solution of 3 
compound MEB55 after one day. XTT measurements for the determination of cell viability were 4 
carried out 48h-after exposure to compound MEB55.  5 
EGOBP. Spatial hormone distribution is actively regulated by plants at multiple levels, such as 6 
biosynthesis, catabolism, and transport to allow specific function to occur. The level of SL 7 
secretion is also likely to be properly controlled. The Petunia hybrid ABC transporter PDR1 has 8 
recently been isolated.
35
 However, only little is known about the dynamic distribution of SLs, 9 
their precursors, and their derivatives in Arabidopsis in particular.
36
 As part of our work on the 10 
synthesis of fluorescent tagged SL analogues to map the distribution of SLs in plants we 11 
synthesized EGO10 derivatives by linking the EGO10 core to a fluorescent BODIPY based 12 
probe, through a 3-carbon linker (Figure 2, EGO BP A 9 and EGO BP B 10). The activity of 13 
racemic EGO BP had previously been tested on Peliphanche aegyptiaca seeds and found to be a 14 
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 19 
little lower than rac-GR24,
20
 as expected. Racemic EGOBP was resolved in the two enantiomers 1 
EGOBP A (9) and EGOBP B (10) whose absolute configuration was unambiguously assessed 2 
according to ECD data and chiral HPLC behaviour (SI); EGOBP A being the R and EGOBP B 3 
the S enantiomer. Fluorescence emission measurements of A. thaliana seedlings treated with 4 
fluorescent SLs showed a higher accumulation of EGOBP A than EGOBP B in the root. 5 
Moreover EGOBP A was the most active root hair elongation  analogue. Controls were 6 
performed using fluorophore BODIPY(naked-BP) alone which led to non-specific tissue 7 
distribution and with EGOBP which was missing the D-ring and the enol ether connecting bridge 8 
which also lead to nonspecific distribution. Given these preliminary but clear-cut results EGOBP 9 
A was then chosen as the lead candidate with which to follow the distribution and transport of 10 
SLs in Arabidopsis.
37
 11 
BPGR24. Because of its widespread use and the huge body of data available on its biological 12 
activity in different organisms we functionalized the universal standard GR24 with the same 13 
fluorescent probes BODIPY and assessed the bioactivity of the four stereoisomers (Figure  2).  14 
 15 
0
10
20
30
40
50
60
70
80
90
100
Acetone GR24 GR24-BP D1 RAC GR24-BP D1 A GR24-BP D1 B GR24-BP D2 RAC GR24-BP D2 A GR24-BP D2 B
% Germination
a
f
a, e
a
a
f, e f
d, e
 20 
Figure 10. Bar graph representation of percentages of germinated seeds (Y axis) of Peliphanche 1 
aegyptiaca after exposure to pure enantiomers of the GR24 BP serie at 0.1 µM concentration  2 
The germination stimulatory activity of all four GR24 BP stereoisomers was measured towards 3 
Peliphanche aegyptiaca seeds. The results shown in Figure 10 surprisingly revealed that the D1 4 
diastereoisomer is completely inactive and statistically comparable to the negative control 5 
acetone, whether used as a racemic mixture or a pure enantiomer. It is worthwhile  emphasizing  6 
that GR24, whether used as a racemic or a pure enantiomer (rac-GR24 vs. (+) GR24 and (-) ent 7 
GR24) shows the predicted germination activity. Besides, the D2 diasteroisomers show 8 
germination activity that is comparable to rac-GR24 both as racemate and as pure enantiomer 9 
(2′-epi BPGR24 14 and ent-2′-epi GR24BP 13). This was then chosen as the lead candidate for 10 
bioimaging studies into SL transport and distribution in living organisms.
38
 11 
In this study, the absolute configuration of a series of enantiomerically pure SL analogues by 12 
means of X-ray analyses of one of the compounds and by the comparative analysis of the ECD 13 
spectra of all family members were elucidated. This was based on the fine correlations found 14 
within the whole family of compounds and with the literature data.   15 
Recent findings demonstrate that configuration at C-2′  position (D-ring) plays a crucial role in 16 
the activation of  specific SL related responses.
32
 As configuration has been proven to be a 17 
significant determinant of SL activity, we examined multiple physiological responses in various 18 
organisms in order to correlate absolute configuration to activity. We use parasitic seeds 19 
germination (Peliphanche aegyptiaca), hyphal branching (Gigaspora margarita), root elongation 20 
(Arabidopsis thaliana),  and cell cycle arrest of cancer and non-cancer cell lines as the biological 21 
targets. Wherever selectivity towards one of the two enantiomers is observed, the enantiomer 22 
 21 
with 2′R configuration is the most active. In the Orobanchaceae, S. hermontica seeds are reported 1 
to respond to all stereoisomers of GR24
1a
 and deoxystrigol
30
 with a slight preference for isomers 2 
with the same configuration as natural strigol. The four stereoisomers of deoxystrigol have 3 
recently been tested on Orobanche minor and it was found that the stereoisomer with the same 4 
configuration as orobanchol was the most active while its enantiomer the least so.
32
 However, 2′-5 
epi BPGR24 (14, 2’ S) is the most active fluorescent derivative of GR24.  6 
In summary, the present work represents an elucidation of the absolute configurations of some of 7 
the most potent SL analogues that have been designed for specific purposes, and the correlation 8 
between stereochemistry and biological response.  9 
EXPERIMENTAL SECTION 10 
General Experimental Procedures. 
1
H NMR and 
13
C NMR spectra were recorded on a Bruker 11 
Avance-200 spectromer. 
1
H NMR spectra were recorded at 200 MHz, 
13
C NMR and DEPT 12 
spectra at 50 MHz. ESIMS data were recorded using an LCQ Deca XP plus spectrometer 13 
(Thermo) spectrometer with an electrospray interface and ion trap as a mass analyzer; sheath gas 14 
flow rate was set at 25 (arbitrary unit), auxiliary gas flow rate at 5 (arbitrary unit), spray voltage 15 
at 3.25 (KV), capillary temperature at 270 °C, capillary voltage at −7 (V), and tube lens offset at 16 
−60.00 (V). Nitrogen was used as a sheath and auxiliary gas. HRMS data were recorded on an 17 
LTQ Orbitrap Hybrid Mass Spectrometer. MS data were recorded at an ionizing voltage of 70 18 
eV. Chromatographic separations were carried out on silica gel (Merck Grade 7734, pore size 60 19 
Å, 70-230 mesh); Rf values refer to TLC carried out on 0.25-mm silica gel plates (Merck F254), 20 
with the same eluent indicated for the column chromatography. The enantiomers were separated 21 
on either a semi-preparative and an analytical Chiralpak IC column (particle size 5 μm, Daicel, 22 
 22 
Osaka, Japan). Dimensions: Analytical column 4.6 Φ  x 250 mmL; Semiprep. column 10 Φ  x 1 
250 mmL. All the chemicals were purchased from Sigma-Aldrich and were used as received 2 
unless stated otherwise. Column chromatography purifications was performed via classical 3 
chromatography. Compounds 15, 17, 18,  and 19 were synthesized as previously reported.
25
 The 4 
glassware used for classical syntheses was heated overnight in an oven at 150°C and assembled 5 
in the oven, then cooled under argon flux before starting the reactions. A Jasco P-2000 6 
polarimeter was used for the determination of optical rotations. ECD measurements were 7 
performed on a JASCO J-815 instrument at RT, in quartz cells with 1 mm optical path; scanning 8 
speed 100 nm/min, bandwidth 1 nm.   9 
Biological Tests. Plant material. Seeds of Peliphanche aegyptiaca were collected from field 10 
grown tomato in the West Galilee in Israel. The seeds were stored in glass vials in the dark at 11 
room temperature until used in germination tests. Preparation of test solutions: the compound to 12 
be tested were weighted out accurately and dissolved in 1 mL of acetone and then diluted with 13 
sterile distilled H2O to reach the appropriate concentrations. All solutions were prepared just 14 
before use. Seeds were surface sterilized and preconditioned according to the experimental 15 
procedure indicated in ref. 31. Briefly, seeds were exposed to 50% (v/v) aqueous solutions of 16 
commercial bleach for 5 min (2% hypochlorite) and rinsed with sterile distilled H2O. For 17 
preconditioning, seeds were sown on a glass fibre filter paper disc using a sterile toothpick 18 
(approximately 20 seeds per disc), the glass fibre discs were placed on 2 filter paper discs, 19 
dampened with sterile distilled H2O and incubated at 25 °C in the dark for 6 days. The 20 
preconditioned seeds were then allowed to dry completely in the laminar flow, treated with the 21 
strigolactone analogue solutions and germination rate was evaluated under a stereomicroscope 7 22 
days after treatment. At least 100 seeds were analyzed at each concentration, synthetic 23 
 23 
strigolactone GR24 10
-7
M was included as the positive control while an aqueous solution of 1 
0.1% acetone and sterile distilled H2O was included as the negative control. Seeds were 2 
considered to be germinated if the radicle protruded through the seed coat. 3 
Fungal Material. Spores of Gigaspora margarita Becker and Hall were collected from a 4 
previously established trap culture of clover, sterilized with a solution of chloramine T (3% P/V) 5 
and streptomycine sulphate (0,03% P/V), rinsed with distilled H2O and placed in a Petri plate 6 
filled with 0.2 % Phytagel gel (Sigma-Aldrich) containing 3 mM MgSO4. The plates were 7 
incubated vertically for 5 days at 30 °C in the dark. Paper discs (6 mm diameter), loaded with the 8 
strigolactone analogue solution, were positioned on either side of the germinating hyphae tips. 9 
The number of newly formed hyphal apex was recorded 24 h after treatment. GR24 10
-7
M was 10 
included as positive control, while an aqueous solution of 0.1% acetone and sterile distilled H2O 11 
was included as negative control. 12 
XTT Cell Proliferation Assay. Cells were seeded into a 96 well plates at 2,500 cells per well in 13 
triplicates in normal growing media. The following day, the media was replaced with phenol red-14 
free DMEM supplemented with 10% FBS (Foetal Bovine Serume) and 5% penicillin-15 
streptomycin solution.  Cells were incubated over night at 37 °C in a humidified 5% CO2-95% 16 
air atmosphere, and then were treated as indicated below for 48h. An XTT (2, 3,-bis(2-methoxy-17 
4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium inner salt) reduction was used 18 
to quantify viability according to manufacturer’s instruction (Biological industries, IL). Cells 19 
were incubated with XTT reagent for 2 h at 37 °C in a humidified 5% CO2-95% air atmosphere.  20 
Absorbance was recorded on a VersaMax ELISA Microplate Reader (Molecular devises, USA) 21 
at 450 nm with 650 nm being the reference wavelength. Cell survival was estimated from the 22 
equation: % cell survival of control= 100 × (At-Ac)(treatment) / (At-Ac)(control), where At and 23 
 24 
Ac are the absorbencies (450nm) of the XTT colorimetric reaction in treated and control cultures 1 
respectively minus non-specific absorption measured at 650nm. Absorbance of the medium 2 
alone was also deducted from specific readings. Data points were connected by non-linear 3 
regression lines of the sigmoidal dose-response relation in dose response assays. 4 
7-Amino-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one (16): A solution of 15 (3.12 mmol, 5 
0.684 g) in 4.8 mL of EtOH was added to an aqueous solution of CaCl2 (2.18 mmol, 0.684 gin 6 
3.6 mL of water) in a three-necked round bottom flask. Zn powder was then added (27.52 mmol, 7 
1.80 gr) and the resulting suspension was heated to reflux temperature (80 °C) and reacted for 2 8 
hours. Upon TLC control (petroleum ether/EtOAc, 1/1, Rf = 0.21), which indicated the total 9 
consumption of the starting material, the reaction mixture was filtered on a Büchner funnel and 10 
washed with CH2Cl2. The organic phases were washed with brine (1x 25 mL) and H2O (2x 25 11 
ml), dried over K2CO3, filtered and the solvent was evaporated. Compound 2 [0.420 g (80% 12 
yield)] was obtained as a whitish solid and did not require further purification. 
1
H NMR (CDCl3, 13 
200 MHz): δ 2.30 (1H, dd, J = 18 Hz, J = 5.8 Hz, H3a), 2.63-2.86 (2H, m, H3), 3.05-3-51 (2H, 14 
m, H4), 3.57 (2H, br, NH2), 5.73 (1H, d, J = 7.0 Hz, H8b), 6.61 (1H, dd,  J = 2.0 Hz , J = 8.0 Hz, 15 
H6), 6.71 (1H, d, J = 2.0 Hz, H8), 6.98 (1H, d,  J = 8.4 Hz, H5). Spectroscopic data correspond 16 
to literature reports.
39
 17 
 18 
 25 
rac- BPGR24 (and rac 2′- epi BPGR24). A solution of 2021b  (0.15 mmol, 50 mg) was prepared 1 
in 3 mL of DCM in a three neck round bottom flask, 2-chloro-4,6-dimethoxy-1,3,5-triazine 2 
(CDMT, 0.18 mmol 32 mg) was then added and the solution was cooled to -5°C. N-3 
methylmorpholine (NMM) was added and the mixture reacted for 2 hours. When the TLC 4 
control ( petroleum ether/ EtOAc 2:3) confirmed the formation of the activated BODIPY 5 
complex (approximately 2h) rac- amino- GR24 19 (or rac- 2′-epi- GR24, 0.150 mmol 47 mg) 6 
was added via cannula. The mixture was reacted at room temperature overnight. A 10% solution 7 
of citric acid was added and the aqueous phases extracted with DCM (10 mL x3). The organic 8 
phases were then dried over Na2SO4, and the solvent evaporated under reduced pressure. The 9 
crude was purified by flash chromatography with hexanes/EtOAc 2:3 (Rf 0.20 green 10 
fluorescence) to give 74 mg (78% yield) of an orange solid of BPGR24/ent-BPGR24. 11 
Separation on chiral HPLC gives pure enantiomers. 12 
BPGR24 (11): [α]25D + 86 (c 0.2, CH2Cl2).  
1
H NMR (CDCl3, 200 MHz): δH 2.04 (5H, s, CH3 D 13 
ring and CH2), 2.39-2.49 (14H, m, CH3 BODIPY and CH2), 2.98-3.06 (3H, m, H4 and CH2), 14 
3.29-3.42 (1H, m, H4), 3.88-3.97 (1H, m, H3a), 5.88 (1H, d, J = 7.8 Hz, H8b), 6.03 (2H, s, 15 
BODIPY), 6.17 (1H, br, H3’), 6.96 (1H, br, H2’), 7.13 (1H, d, J = 8.0 Hz, H5), 7.47-7.56 (3H, 16 
m, H6, H6’ and H8). 13C NMR (CDCl3, 50 MHz): δC 10.7 (2 CH3 BODIPY), 14.4 (2 CH3 17 
BODIPY), 16.4 (CH3 D- ring), 27.2 (CH2CH2CH2CONH), 27.4 (CH2CH2CONH), 36.9 18 
(CH2CH2CH2CONH), 37.0 (CH2 C-4a), 39.2 (C-3a), 85.9 (C-8b), 100.7 (C-2’), 113.2 (C-4), 19 
117.5 (C-3’), 121.8 (CH-BODIPY), 122.3 (phenyl C-5), 125.6 (C-6’), 131.5 (phenyl, C-3), 135.9 20 
(2C, BODIPY), 137.5 (2C, BODIPY), 138.2 (C, BODIPY), 139.3 (2C, BODIPY), 140.7 (C-4a), 21 
141.0 (phenyl, C-6), 145.3 (C-8a), 151.3 (phenyl, C-8), 154.0 (C-7), 170.2, 171.5 (CONH);  22 
ESIMS m/z 652,3 [M+Na]
+
; HRESIMS m/z 629.2339 (calcd for C34H34BF2N3O6: 629,2509). 23 
 26 
ent-BPGR24 (12): [α]25D -82 (c 0.2, CH2Cl2). 
1
H NMR (CDCl3, 200 MHz): δH 2.05 (5H, s, CH3 1 
D ring and CH2), 2.39-2.51 (14H, m, CH3 BODIPY and CH2), 2.98-3.06 (3H, m, H4 and CH2), 2 
3.30-3.43 (1H, m, H4), 3.90-3.98 (1H, m, H3a), 5.90 (1H, d, J = 7.8 Hz, H8b), 6.04 (2H, s, 3 
BODIPY), 6.19 (1H, br, H3’), 6.99 (1H, br, H2’), 7.14 (1H, d, J = 8.0 Hz, H5), 7.50-7.57 (3H, 4 
m, H6, H6’ and H8). 13C NMR (CDCl3, 50 MHz): δC 10.9 (2 CH3 BODIPY), 14.6 (2 CH3 5 
BODIPY), 16.5 (CH3 D- ring), 27.5 (CH2CH2CH2CONH), 27.6 (CH2CH2CONH), 37.1 6 
(CH2CH2CH2CONH), 37.2 (CH2 C-4a), 39.3 (C-3a), 86.2 (C-8b), 100.9 (C-2’), 113.4 (C-4), 7 
117.7 (C-3’), 121.9 (CH-BODIPY), 122.5 (phenyl C-5), 125.7 (C-6’), 131.7 (phenyl, C-3), 136.0 8 
(2C, BODIPY), 137.7 (2C, BODIPY), 138.3 (C, BODIPY), 139.4 (2C, BODIPY), 140.9 (C-4a), 9 
141.2 (phenyl, C-6), 145.6 (C-8a), 151.6 (phenyl, C-8), 154.1 (C-7), 170.4, 171.8 (CONH); 10 
ESIMS m/z 652,3 [M+Na]
+
; HRESIMS m/z 629.1416 (calcd for C34H34BF2N3O6: 629,2509). 11 
2’-epi-BPGR24 (14): [α]25D + 148 (c 0.2, CH2Cl2). 
1
H NMR (CDCl3, 200 MHz): δH 2.05 (3H, s, 12 
CH3 D ring), 2.42-2.51 (16H, m, CH3 BODIPY and 2xCH2), 3.02-3.10 (3H, m, H4 and CH2), 13 
3.32-3.45 (1H, m, H4), 3.90-4.01 (1H, m, H3a), 5.91 (1H, d, J = 7.8 Hz, H8b), 6.04 (2H, s, 14 
BODIPY), 6.18 (1H, br, H3’), 6.97 (1H, br, H2’), 7.16 (1H, d, J = 8.0 Hz, H5), 7.46-7.61 (3H, 15 
m, H6,H6’ and H8). 13C NMR (CDCl3, 50 MHz): δC 10.9 (2 CH3 BODIPY), 14.6 (2 CH3 16 
BODIPY), 16.5 (CH3 D-ring), 27.4 (CH2CH2CH2CONH), 27.6 (CH2CH2CONH), 37.1 17 
(CH2CH2CH2CONH), 37.2 (CH2 C-4a), 39.3 (C-3a), 86.1 (C-8b), 100.9 (C-2’), 113.4 (C-4), 18 
117.7 (C-3’), 121.9 (CH-BODIPY), 122.5 (phenyl C-5), 125.8 (C-6’), 131.7 (phenyl, C-3), 136.1 19 
(2C, BODIPY), 137.6 (2C, BODIPY), 138.4 (C, BODIPY), 139.5 (2C, BODIPY), 140.8 (C-4a), 20 
141.2 (phenyl, C-6), 145.5 (C-8a), 151.5 (phenyl, C-8), 154.2 (C-7), 170.4, 171.7 (CONH).;  21 
ESIMS m/z 652,2 [M+Na]
+
; HRESIMS m/z 629,3516 (calcd for C34H34BF2N3O6: 629,2509). 22 
 27 
ent-2’epi-BPGR24 (13): [α]25D − 175  (c 0.1, CH2Cl2). 
1
H NMR (CDCl3, 200 MHz): δH 2.01 (3H, 1 
s, CH3 D ring), 2.38-2.48 (16H, m, CH3 BODIPY and 2xCH2), 2.98-3.04 (3H, m, H4 and CH2), 2 
3.29-3.40 (1H, m, H4), 3.87-3.98 (1H, m, H3a), 5.88 (1H, d, J = 7.8 Hz, H8b), 6.01 (2H, s, 3 
BODIPY), 6.15 (1H, br, H3’), 6.94 (1H, br, H2’), 7.13 (1H, d, J = 8.0 Hz, H5), 7.43-7.58 (3H, 4 
m, H6,H6’ and H8). 13C NMR (CDCl3, 50 MHz): δC 10.9 (2 CH3 BODIPY), 14.6 (2 CH3 5 
BODIPY), 16.6 (CH3 D-ring), 27.5 (CH2CH2CH2CONH), 27.6 (CH2CH2CONH), 37.0 6 
(CH2CH2CH2CONH), 37.2 (CH2 C-4a), 39.5 (C-3a), 86.0 (C-8b), 100.8 (C-2’), 113.2 (C-4), 7 
117.7 (C-3’), 121.9 (CH-BODIPY), 122.4 (phenyl C-5), 125.7 (C-6’), 131.7 (phenyl, C-3), 136.2 8 
(2C, BODIPY), 137.8 (2C, BODIPY), 138.4 (C, BODIPY), 139.6 (2C, BODIPY), 140.8 (C-4a), 9 
141.1 (phenyl, C-6), 145.5 (C-8a), 151.4 (phenyl, C-8), 154.2 (C-7), 170.4, 171.6 (CONH).;  10 
ESIMS m/z 652,2 [M+Na]
+
; HRESIMS m/z 629,2211 (calcd for C34H34BF2N3O6: 629,2509). 11 
X-ray Analysis. Crystals that were suitable for X-ray diffraction analyses were obtained via the 12 
slow evaporation of a methanol solution. X-ray data were collected on an Oxford Diffraction 13 
Gemini R-Ultra diffractometer equipped Enhanced Ultra (Cu) X-ray Source (mirror 14 
monochromatized Cu-K radiation, =1.5418 Å). The  scan was performed with a frame width 15 
of 1.0°. The intensities were corrected for absorption with the numerical correction based on a 16 
Gaussian integration over a multifaceted crystal model. Softwares used: CrysAlisPro (Agilent 17 
Technologies, Version 1.171.37.31) for data collection, data reduction and absorption correction; 18 
SHELXT
40
 for data solution; SHELXL-2014/7
40
 for refinement; OLEX2 (version 1.2.5)
41
 for 19 
structure analysis and drawing preparation. All non-hydrogen atoms were anisotropically refined. 20 
Hydrogen atoms were calculated and refined riding with Uiso=1.2 or 1.5 Ueq of the atom 21 
connected. The absolute configuration was determined using  Parson’s method (Flack parameter 22 
is reported on S20 of the Supporting Information).
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